Apparatus And Methods For Treating The Aorta

• US 20100087907A1
• Filed: 02/15/2008
• Published: 04/08/2010
• Est. Priority Date: 02/16/2007
• Status: Abandoned Application

• Current Assignee: Emory University
• Original Assignee: Emory University
• Inventors: Lattouf, Omar
• Application Number:
  US12/527,248
• Publication Number:
  US 20100087907A1
• Time in Patent Office: Days
• US Class Current: 623/1.110
• CPC Class Codes: A61B 17/12022 Occluding by internal devices, e.g. balloons or releasable wires plugging an opening in the wall of an organ A61B17/0057; occluders for the cervical canal A61F6/146; vas deferens occluders A61F6/20
• CPC Class Codes: A61B 17/12118 for positioning in conjunction with a stent
• CPC Class Codes: A61B 2017/00243 cardiac
• CPC Class Codes: A61B 2017/1205 Introduction devices
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2/89 the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
• CPC Class Codes: A61F 2/95 Instruments specially adapted for placement or removal of stents or stent-grafts

Abstract

An endovascular stent and an aortic valve replacement can be used to treat the aorta. An endovascular stent suitable for treating the ascending aorta includes a circumferential wall with one or more portions configured to allow blood to flow therethrough, and one or more portions configured to be substantially impermeable. In one version, the blood-permeable portion is defined by bare metal with fenestrations defined therein, and the impermeable portion is formed from polymeric material. The permeable and impermeable portions of the stent are sized, shaped, and located so that, when positioned in the blood vessel to be treated, the impermeable portion is in operative proximity to an aneurysm, dissection, or other area to be treated, and the permeable, bare metal portion is in operative proximity to other blood vessels which need to receive blood from the blood vessel being treated. An aortic valve replacement includes multiple flanges that can be seated in the sinuses of valsalva. The stent or aortic valve replacement may be included in a suitable apparatus for treatment of the aorta. The apparatus for treating the aorta may include a delivery system adapted to be inserted through the apex of the left ventricle of the heart.

Claims

1. A method of treating the aorta comprising:

inserting a delivery device carrying a stent through the apex of the left ventricle;

advancing a distal end of the delivery device from the left ventricle into the aorta; and

controlling the delivery device to position the stent at a desired location on the inner wall of the aorta.

2. The method of claim 1, wherein inserting the delivery device includes inserting the device through a one-way, transapical valve conduit.

3. The method of claim 1, wherein controlling the delivery device includes positioning the stent in one of the ascending aorta and the transverse arch of the aorta.

4. The method of claim 1, wherein the stent is positioned at a location associated with at least one of an aneurysm and a dissection.

5. The method of claim 1, including providing a stent with apertures defined in a circumferential wall of the stent, the apertures sized to permit blood flow therethrough, and positioning the stent within the aorta to locate the apertures in proximity to other arteries receiving blood from the aorta.

6. The method of claim 5, further including:

providing the stent with a longitudinal segment on the circumferential wall without apertures defined therein;

positioning the longitudinal segment within a portion of the aortic wall to be treated; and

positioning the apertures adjacent at least one artery receiving blood from the aorta.

7. The method of claim 1, further including:

providing members for positioning the stent; and

securing the members at spaced locations on the stent;

wherein controlling the delivery device includes operating the members to position the stent at a desired location.

8. The method of claim 1, further comprising:

positioning an aortic valve replacement between the stent and the sinuses of valsalva.

9. The method of claim 8, wherein said positioning step comprises:

inserting a delivery device carrying an aortic valve replacement through the apex of the left ventricle;

advancing a distal end of the delivery device from the left ventricle into the aorta at a location between the stent and the sinuses of valsalva; and

controlling the delivery device to position the aortic valve replacement between the stent and the sinuses of valsalva.

10. The method of claim 8, wherein the aortic valve replacement includes multiple flanges and the flanges are positioned within the sinuses of valsalva.

11. The method of claim 10, wherein the stent includes multiple flanges and the flanges of the aortic valve replacement are directed to be substantially collinear with the flanges of the stent.

12. A method of treating an aortic condition, the method comprising:

providing a stent, the stent having a circumferential wall with at least two zones defined therein, the first zone of the circumferential wall having apertures defined therein, the apertures sized to permit blood to flow therethrough, the second zone of the circumferential wall through which blood substantially does not flow; and

positioning the stent near the aortic valve to locate the first zone in operative proximity to the left main and right coronary arteries, and the second zone in operative proximity to the aortic condition.

13. The method of claim 12, wherein the aortic condition is an aortic dissection or aneurysm.

14. The method of claim 12, wherein the stent has two ends, the circumferential wall extending between the two ends, and wherein the stent is provided with multiple flanges at one of the ends, the method further including seating the stent by positioning the flanges in the sinuses of valsalva of the aortic valve.

15. The method of claim 12, further including carrying the stent through the left ventricle and into the ascending aorta on a distal end of a controllable delivery device.

16. The method of claim 15, further including:

folding the stent into a delivery tube at the distal end of the delivery device; and

securing members at spaced locations on the stent.

17. The method of claim 16, wherein positioning the stent includes moving the delivery tube relative to the dissection.

18. The method of claim 16, wherein positioning the stent includes moving the members.

19. The method of claim 18, wherein positioning the stent includes seating the stent by pulling the members back toward the aortic valve.

20. The method of claim 12, further including applying a cylindrical sheath to the outer aortic wall of the ascending aorta at the site of the dissection.

21. A stent, comprising:

a circumferential wall extending longitudinally between two opposite ends;

a first portion of the circumferential wall having apertures defined therein, the apertures sized to permit blood to flow therethrough; and

a second portion of the circumferential wall configured so that blood substantially does not flow therethrough.

22. The stent of claim 21, wherein the first portion comprises bare metal.

23. The stent of claim 22, wherein the apertures include fenestrations defined by portions of the bare metal.

24. The stent of claim 21, wherein the second portion includes flexible, polymeric material impermeable to fluid.

25. The stent of claim 21, wherein the circumferential wall comprises a frame extending at least partially between the ends, the frame having fenestrations defined therein, the frame partially covered by a polymeric material to define a covered portion and a bare metal portion, the first portion of the circumferential wall corresponding to the bare metal portion, the second portion corresponding to the covered portion.

26. The stent of claim 21, wherein the first and second portions comprise first and second longitudinal segments of the circumferential wall.

27. The stent of claim 26, wherein the first and second longitudinal segments are adjacent to each other.

28. The stent of claim 27, wherein the first segment is located at one of the ends of the circumferential wall.

29. The stent of claim 28, wherein the first segment extends a sufficient length to span the left main and right coronary arteries when the stent is seated in the sinuses of valsalva.

30. The stent of claim 23, wherein the first portion includes two, longitudinal, bare metal segments, one at a proximal end portion of the stent, the other at a distal end portion of the stent.

31. The stent of claim 30, wherein one of the bare metal segments is of sufficient length to span at least one of the arteries extending from the transverse arch.

32. The stent of claim 30, wherein the second portion includes a covered, longitudinal segment between the two bare metal segments, the three segments being sized and located so that, when the stent is located adjacent the aortic valve, the first bare metal segment spans the coronary arteries and the second bare metal segment at least partially spans the three arteries extending from the transverse arch comprising the innominate artery, the left common carotid, and the left subclavian.

33. The stent of claim 21, further comprising flanges extending from one of the ends of the stent, the flanges located and configured to engage the sinuses of valsalva.

34. The stent of claim 33, wherein the flanges comprise pods formed from loops of wire.

35. The stent of claim 21, further comprising an outer aortic sheath adapted to be positioned on the other side of the aortic wall opposite the circumferential wall of the stent.

36. The stent of claim 21, wherein:

the second portion includes a valve and flanges such that, when the stent is located adjacent the aortic valve, that flanges engage the sinuses of valsalva; and

the first portion is distal to the second portion within the aorta.

37. An apparatus for treatment of the aorta comprising:

a stent having an endoaortic circumferential wall extending longitudinally between two, opposite ends, a first portion of the circumferential wall having apertures defined therein, the apertures sized to permit blood to flow therethrough, a second portion of the circumferential wall configured so that blood substantially does not flow therethrough;

a delivery system for transapical insertion of the stent, the system comprising a transapical valve conduit and a delivery device, the delivery device having a delivery tube adapted to carry the stent and a controller for positioning the stent relative to the aorta, the controller including a shaft with a first distal end secured to the stent and second end extending toward the proximal end of the delivery tube; and

an outer aortic sheath adapted to be positioned on the outer aortic wall.

38. A method of treating the aorta comprising:

inserting a delivery device carrying an aortic valve replacement through the apex of the left ventricle;

advancing a distal end of the delivery device from the left ventricle into the aorta; and

controlling the delivery device to position the aortic valve replacement at a desired location on the inner wall of the aorta.

39. The method of claim 38, wherein inserting the delivery device includes inserting the device through a one-way, transapical valve conduit.

40. The method of claim 38, further including:

providing members for positioning the aortic valve replacement; and

securing the members at spaced locations on the aortic valve replacement;

wherein controlling the delivery device includes operating the members to position the aortic valve replacement at a desired location.

41. A method of providing an aortic valve replacement to the aorta, the method comprising:

providing an aortic valve replacement, the aortic valve replacement comprising a valve and multiple flanges at one of the ends, and

positioning the flanges of the aortic valve replacement in the sinuses of valsalva of the aortic valve.

42. The method of claim 41, further including carrying the aortic valve replacement through the left ventricle and into the ascending aorta on a distal end of a controllable delivery device.

43. The method of claim 41, wherein positioning the aortic valve replacement includes securing members at spaced locations on the proximal end of the aortic valve replacement and seating the aortic valve replacement by pulling the members back toward the sinuses of valsalva.

44. An aortic valve replacement, comprising:

a generally cylindrical member comprising a valve located within the generally cylindrical member and multiple flanges at an end of the generally cylindrical member;

wherein the flanges are configured to be positioned into the sinuses of valsalva.

45. The aortic valve replacement of claim 44, including three flanges separated by approximately 120°

of arc.

46. An apparatus for providing an aortic valve replacement, comprising:

an aortic valve replacement formed of a generally cylindrical member and having a valve located within the generally cylindrical member and multiple flanges at an end of the generally cylindrical member;

a delivery system for transapical insertion of the aortic valve replacement, the system comprising a transapical valve conduit and a delivery device, the delivery device having a delivery tube adapted to carry the aortic valve replacement and a controller for positioning the aortic valve replacement relative to the aorta, the controller including a shaft with a first distal end secured to the aortic valve replacement and second end extending toward the proximal end of the delivery tube.